Vol.
36
No.
8
August 30, 2013Aug 30, 2013
Free

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

CMX001 Reduces Adenovirus Progression and Viremia

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

Pretreatment with Azacitidine Achieves 28-Month Remission

Specific Pathology Pattern Can Predict Recurrence

20% of Women Do Not Believe Tailored Risk Assessments

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

NCI CTEP Approved Trials For the Month of August

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

Login